NMDAE plus AIFA

DRUG2 trials

Sponsors

China Medical University Hospital

Conditions

Schizophrenia

Phase 2

Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia

RecruitingNCT04917302

China Medical University HospitalSchizophrenia

Start: 2020-10-13End: 2026-12-31Target: 60Updated: 2025-02-19

Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia

RecruitingNCT05240976

China Medical University HospitalSchizophrenia

Start: 2022-02-23End: 2027-03-01Target: 80Updated: 2026-03-24